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Objective: To explore the immunological mechanisms underlying the effect of chronic intermittent hypobaric
hypoxia (CIHH) pretreatment on collagen-induced arthritis (CIA) in rat.
Methods: Fifty-four adult male Sprague–Dawley rats were used in the experiment. Arthritis in CIA rats (n=18) was
induced by injection of collagen. The CIHH+CIA rats (n=18) were treated with CIHH (simulated 3000 m altitude,
5 hours per day for 28 days, PO2=108.8 mmHg) before CIA. The control rats (n=18) were not given any treatment.
Results: (1) Incidence rate of CIA in CIHH+CIA rats was significantly lower than that in CIA rats (P<0.05). (2) The paw
thickness and arthritis index (AI) value in CIHH+CIA rats were lower than those in CIA rats (P<0.05). (3) The
hyperplasia with inflammatory infiltration in synovial tissue of joints in CIHH+CIA rats was much alleviative
compared with CIA rats. (4) TNF-α, IFN-γ, IL-4 and IL-17 in synovial tissue of joint and serum in CIHH+CIA rats were
decreased compared with CIA rats (P<0.05). (5) The number of CD4-positive T-lymphocytes and the ratio of CD4/
CD8 T-lymphocytes in peripheral blood in CIHH+CIA rats were lower than those in CIA rats (P<0.05). (6) The protein
expression of HIF-1α and NF-κB in synovial tissue of joint in CIHH+CIA rats was decreased compared with CIA rats
(P<0.05).
Conclusion: CIHH pretreatment has a protective effect against collagen-induced arthritis in rat through
down-regulation of HIF-1α and NF-κB, inhibition of inflammatory cytokines TNF-α and IL-17, and balance in CD4/
CD8 and Th1/Th2 T lymphocytes.
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induced inflammatory disease, is characterized as chronic,
symmetrical, multi-synovium arthritis and pathological
changes outside joints. The collagen-induced arthritis
(CIA) rat model is a good experimental model for study
mechanisms of arthritis and is demonstrated to have cellu-
lar immunity abnormality in arthritis [1]. Because the
pathological changes in the blood and the articular tissue
in the model are similar to those in human RA, the CIA
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unless otherwise stated.date, the mechanism of RA is not fully understood and
there is no specific and effective therapy for RA treatment.
Accumulating evidence showed that chronic intermit-
tent hypobaric hypoxia (CIHH) has beneficial effects on
the body. For example, CIHH protects heart, central
nervous system, and liver against ischemia/reperfusion
or hypoxia/reoxygenation injuries [2-4]. Also, CIHH ex-
erts anti-hypertension effect [5]. Furthermore, CIHH has
been widely used in sports training to enhance the toler-
ance of organs and tissues to anoxia [6]. It was reported
that CIHH had a positive treatment effect on bronchial
asthma, which suggests that CIHH has a beneficial ac-
tion on immune function [7]. Our previous study has
shown that CIHH treatment recovered the immuno-
logical dysfunction induced by acute hypoxia throughs is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cing the disturbance of T-lymphocytes subgroups [8].
Recently, our group found that CIHH pre-treatment
could diminish the incidence of CIA and alleviate the
symptoms of CIA in rats, which may related to CIHH
enhancing apoptosis in synovial cells and T lymphocytes
[9]. The aforementioned suggest that CIHH has benefi-
cial effect on immune system by modulating the im-
munological function and lymphocytes activity. But the
detail immunological mechanism underlying protection
of CIHH against CIA remains unclear. So we proposed a
hypothesis that CIHH protects CIA through inhibiting
inflammatory reaction and keeping the balance of lym-
phocytes activity. The primary objective of this study
was to investigate the protective effect of CIHH against
CIA and the anti-inflammation action of lymphocytes in
the protective effect of CIHH, and the second objective
was to confirm the signaling molecule like HIF-1α and
NF-κB in CIHH effect. The present study demonstrated
that CIHH pretreatment has a protective effect against
collagen-induced arthritis in rat through down-regulation
of HIF-1α and NF-κB, inhibition of inflammatory cyto-




Bacillus Calmette-Guerin Vaccine (BCG) frozen powder
(80 mg/vial) was purchased from Beijing institute of bio-
logical products. Complete Freund’s adjuvant (10 ml/vial)
and Bovine collagen type II (C-7806) were purchased from
Sigma Co. USA. Tumor necrosis factor-α (TNF-α), IFN-γ,
IL-4 and IL-17 ELISA kits were purchased from Shanghai
Sengxiong Technological Co. China. Fluorescein isothio-
cyanate (FITC)-conjugated anti-rat CD4 antibody and allo-
phycocyanin (APC)-conjugated anti-rat CD8 antibody were
purchased from eBioscience USA. Anti-rat TNF-α, IFN-γ,
IL-4 and IL-17, monoclonal anti-rat HIF-1α and NF-κB, and
horseradish peroxidase (HRP) were purchased from Santa
Cruz Biotechnology, USA. SP9001 kit and DAB (3,3’-diami-
nobenzidine) color reagent were purchased from Beijing
Zhongshan Jinqiao Biotech Co. Ltd. China. BCA kit was
purchased from Pierce Co. USA.
Animal group and protocols
All experiments were carried out in compliance with the
Guide for the Care and Use of Laboratory Animals (National
Research Council, 1996) and was reviewed and approved by
the Ethics Committee for the Use of Experimental Animals
at Hebei Medical University. Fifty-four adult male Sprague–
Dawley rats (provided by Experimental Animal Center of
Hebei Medical University, body weight 130-150 g,) were
randomly divided into 3 groups: CIA, CIHH plus CIA
(CIHH+CIA) and Control groups. CIA rats (n=18) receivedcollagen injection to induce CIA. CIHH+CIA rats (n=18) re-
ceived CIHH treatment (simulating 3000 m altitude, 5 hours
per day for 28 days, PO2=108.8 mmHg) in a hypobaric
chamber before collagen injection. Control rats (n=18) re-
ceived local injection of physiological saline.
The healthy condition and physical activity of the rats
were monitored daily, and the body weight and paw thick-
ness were measured and recorded every week. The blood
samples from carotid artery and synovial tissue samples in
the joints of hind paws of anesthesia rats were collected at
end of experiments. The rats were sacrificed with over-
dose of pentobarbital sodium (100 mg/kg, i.v) after samples
collection. In our study, preparation of CIA rats, collection
of sample and measurement of outcomes were performed
by a same skillful person respectively to reduce subjective
and artificial errors.
Protocols
The whole duration for animal treatment lasts 49 days.
For CIHH+CIA rats, CIHH treatment was given from
1st day to 28th day, a collagen injection was given at
29th day, and the samples of blood and synovial tissue
in joints of hind paws were collected to assess the out-
comes at 49th day. For CIA rats, a collagen injection
was given at 29th day, and the samples of blood and syn-
ovial tissue were collected at 49th day. For Control rats,
a physiological saline injection was given at 29th day,
and the samples of blood and synovial tissue were col-
lected at 49th day.
Induction of arthritis
Bovine collagen type II (1 mg/ml) was dissolved in 0.1 M
acetic acid, and kept overnight at 4°C, then emulsified fully
with BCG (10 mg/ml) and equivalent volume of complete
Freunds adjuvant (CFA). The emulsified agent containing
collagen of 0.2 ml was injected in the back or at the base of
the tail, with 6–8 points per rat, to induce arthritis. For con-
trol rats, equivalent volume of physiological saline solution
for collagen preparation was injected in multiple points.
Arthritic Index (AI) was determined by the degree of red-
ness and swelling of the joints and was used to evaluate the
severity of arthritis [10]. Grade 0 of AI represents no edema
and swelling in the joint; Grade 1 represents slight edema
and erythema limited to the foot and/or ankle; Grade 2 rep-
resents edema and erythema toes and most joints of the an-
kles; Grade 3 represents severe edema and erythema paw
below ankle joint; Grade 4 represents edema and erythema
of all paws including ankle joint. The model of arthritis was
considered successful when AI > 5. The evaluation was per-
formed each week.
CIHH treatments
In the CIHH treatment, a vacuum pump was used to
pump air out of the hypobaric chamber, resulting in the
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same time, fresh air flow into the chamber through a
small ventilation hole to keep enough fresh air for the
animal breath. For the safety of animal, the decompres-
sion speed was controlled below 2.5 m/s by a ventilation
valve. It is about 20 min for the air pressure in the
chamber to reach 108.8 mmHg that represents the air
pressure at 3000 m altitude. After 5 hours hypobaric
hypoxia simulating 3000 m altitude, the pump is turned
out and the chamber pressure was increased gradually
to the atmosphere pressure (The increase speed is below
2.5 m/s).
Preparation of articular synovium
The rats were anesthetized with pentobarbital sodium
(50 mg/kg ip) and fixed in supine position. The skin on
the legs was cut longitudinally to expose the area of knee
joint. The ligament and soft tissues above the patella
were cut off. Blunt dissection was performed to separate
synovial and fibrous layers and to fully expose synovial
tissues. One of synovial tissue was cut off and put into
4% paraformaldehyde for histopathology examination and
immunohistochemical staining. Another synovial tissue
was quickly put into liquid nitrogen and kept for
15 min, and then shift into −80°C for measuring the pro-
tein expression of HIF-1α and NF-κB by using Western
blots method.
Histopathology of articular synovium
After routine dehydration and paraffin embedding, the
synovium tissue was cut to 5 μm-thick sections that
were used to haemotoxylin-eosin (HE) staining and im-
munohistochemical staining. Pathological hyperplasia,
inflammatory infiltration, and pannus development in
articular synovium were observed under optical micro-
scope after HE staining.
Immunohistochemical staining and Immunohistochemisty
score in articular synovium
Immunohistochemical staining of streptavidin-perosidase
for TNF-α, IFN-γ, IL-4 and IL-17 were performed accord-
ing to the procedures described by the manufacture of the
staining kit. The results were judged based on chromo-
genic reaction after staining. A brownish yellow color indi-
cated positive staining in the cytoplasm of the synovial
tissue. At least five visual fields was observed in one section
and the percentage of the positive was calculated as the
brownish yellow colored cells over total number of cells.
We also determined the Immunohistochemisty Score
(IHS) as the following [11]: IHS = A×B in which A
stands for positive cell count grading (0~1% = grade 0,
1~10% = grade 1, 10~50% = grade 2, 50~80% = grade 3,
and 80~100% = grade 4), and B stands for intensity of
positive cell coloration (0 represents negative, 1 representsweak positive, 2 represents positive, and 3 represents
strong positive).
Measurement of TNF-α, IFN-γ, IL-4 and IL-17 in serum
Blood sample (3 ml for each rat) was collected from intub-
ation in common carotid artery and centrifuged for 5 min
(3000 r/min) to get serum. The serum was kept at −20°C
for using. Enzyme linked immunosorbent assay (ELISA)
was used to determine the content of TNF-α, IFN-γ, IL-4
and IL-17 in the serum. According to the procedures indi-
cated in kit, optical density value was recorded at 450 nm
on the ELISA (Multiskan Spectrum1500, TEC Co., US)
15 min after the cessation of the reaction. The concentra-
tion of TNF-α, IFN-γ, IL-4 and IL-17 was obtained from
standard log-log graph.
Determination of subsets of CD4 and CD8 on the
T-lymphocyte in the peripheral blood
Blood sample was collected in the same way as mentioned
above. Flow cytometry was used to determine the subsets
of lymphocyte CD4 and CD8. One ml blood was mixed
fully with the anti-coagulant in a ratio of 1:9 the anti-
coagulating vacuum tube. Corresponding fluorescence la-
beling monoclonal antibodies against CD4 (5 μl) and CD8
(5 μl) were added into the tubes containing 100 μl aliquot
of blood and anticoagulant mixture, respectively. The con-
tents in the tubes were mixed vertically and kept for
20 min at room temperature in the dark. Then, 50 μl he-
molysin was added into each tube. After mixture and the
tubes were mixed and kept for 10 min in the dark, pure
water 500 μl was added. After hemolysis completed and
phosphate buffered saline (PBS, 3 ml) added, the tube was
centrifuged for another 3–5 min at 1200 r/min. The super-
natant was decanted and the sedimented cells were ob-
tained and kept at 4°C. At least 10,000 cells for each
sample were obtained and analyzed by Cellquest software.
Determination of HIF-1α and NF-κB in articular synovium
tissue
Western blot technique was used to determine the expres-
sion of HIF-1α and NF-κB proteins in articular synovium
tissue. The synovial tissues were homogenated and centri-
fuged at 12000 r/min for 5 min at 4°C. Supernatant was
collected and protein concentration in supernatant was
quantified using BCA method. The supernatant, each with
equal protein loading, was subjected to SDS-PAGE and
electrotransferred to the membrane. Blots were incubated
firstly with the primary antibody against NF-κB (Santa
Cruz Biotechnology. USA, 1:250 dilution) or HIF-1α
(Santa Cruz Biotechnology.USA, 1:200 dilution) for 2 h
and then with a secondary antibody against IgG (Santa
Cruz Biotechnology.USA, 1:10 000 dilution) for 1 h after
washed with PBS-Tween for three times. Blots were
developed using DAB color reagent. The protein in
Figure 1 Rat model of collagen-induced arthritis (CIA). A. Scab with ulcer on the tail and back in CIA rat; B. Red swelling of the paws in CIA
rat; C. Normal paws in control rat.
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one analysis software and normalized to scanning sig-
nals of GADPH.
Statistics
The data were expressed as mean ± SEM. To compare
the differences of body weight, paw thickness, AI, IHS,
CD4 and CD8-positive T-lymphocytes in peripheral
blood, and Inflammatory cytokines such as TNF-α, IFN-
γ, IL-4 and IL-17 in synovium and serum, as well as
HIF-1α and NF-κB in synovium tissue within the experi-
mental groups, one-way Analysis of Variances (ANOVA)
followed by a Dunnett’s post hoc test was performed.
For the enumeration data (the incidence rate of CIA),
expressed as percentage, was analyzed by x2 test. P < 0.05
was considered statistically significant.
Results
General state of animals
The rats in control group were healthy as indicated by
increased body weight, lustrous hair, normal physical ac-
tivity, and free movement, while the rats treated with
collagen were unhealthy, as indicated by lower gain of
body weight, weariness, withered hair, and reduced phys-















































Figure 2 Chronic intermittent hypobaric hypoxia pretreatment improve
arthritis rat. Chrinic intermittent hypobaric hypoxia (CIHH) pretreatment antag
thickness (B), and decreased the Arthritic Index (C) in collagen-induced arthritis
CIHH treated CIA group; Data were expressed as mean ± SEM, n = 6 for each gback and tail skin surrounding the injection site in the
third day after collagen injection. The ulcers experienced
hard crusts formation, drop off, and healing during 7 to
10 days after collagen injection (Figure 1A). The skin
surrounding the injection sites were red with slight
swelling in the fourteenth day after collagen injection.
The swelling in the ankles, especially hind ankles, was
gradually aggravated and reached to the peak in the
Eighteenth day (Figure 1B). Then the swelling was allevi-
ated gradually but the joints became stiff and the move-
ments of the limbs were limited.
The body weight of CIA rats was significant lower
in the twenty-first day after collagen injection com-
pared with CIHH+CIA and control rats (P < 0.05,
Figure 2A). There was no significant difference of body
weight between CIHH+CIA and control rats (P > 0.05,
Figure 2A).
The effect of CIHH on the incidence rate of CIA
In CIHH+CIA group, 4 out of 20 (20%) rats developed
collagen-induced arthritis. However, 14 out of 20 (70%)
rats in CIA group developed collagen-induced arthritis.
The incidence rate of collagen-induced arthritis in
CIHH+CIA group (20%) was significantly lower than






















s body weight, paw thickness and Arthritic Index in collagen-induced
onized the decrease of body weight (A) and the increase of paw
rat. AI: arthritis index; CIA: collagen-induced arthritis group; CIHH+CIA:
roup, *p<0.05 vs CIA, #p<0.05 vs control.
Table 1 Effect of chronic intermittent hypobaric hypoxia








CIA 20 14 70
CIHH+CIA 20 4 20*
x2=10.101, *P < 0.05 vs CIA group.
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The paw thickness in CIA rats was significantly in-
creased in the fourteenth day after collagen injection
(8.66 ± 0.44 mm) compared with that before collagen in-
jection (6.08 ± 0.10 mm, P < 0.05). The paw thickness of
CIHH+CIA rats was lower than that in CIA rats from
the fourteenth day to the twenty-first day after collagen
injection (P < 0.05, Figure 2B).
AI value in CIA rats was increased significantly in the
fourteenth day after collagen injection (P < 0.05). AI in
CIHH+CIA rats was lower than that in CIA rats from
the fourteenth day to the twenty-first day after collagen
injection (P < 0.05, Figure 2C).
The effect of CIHH on articular synovium pathology in rats
Normal histology of articular synovium has 1–2 layers of
synovial lines, with regular epithelial cells in the flat syno-
vium, and no inflammatory infiltration or angiogenesis
(Figure 3A). The articular synovium in CIA rats displayed
obvious hyperplasia with inflammatory infiltration in liner
and underlayer of liner (Figure 3B). There was no sig-
nificant difference of synovium architecture between
CIHH+CIA and control rats (Figure 3C).
The effect of CIHH on CD4 and CD8-positive T-
lymphocytes in blood of rats
The CD4 -positive T-lymphocytes were increased (30.58 ±
1.59), while the CD8-positive T-lymphocytes decreasedFigure 3 Effect of chronic intermittent hypobaric hypoxia (CIHH) pre
collagen-induced arthritis rat. A: Control rats displayed normal synovia
hyperplasia with inflammatory infiltration in liner and underlayer of liner;
difference from control rats. (H-E staining × 100).remarkably (22.47 ± 1.63) in peripheral blood of CIA
rats. The ratio of CD4/CD8 T-lymphocytes in CIA rats
was elevated compared with CIHH+CIA rats (P<0.05).
However, there was no significant difference of CD4 and
CD8 T-lymphocytes between control and CIHH+CIA
rats (P >0.05, Table 2).
The effect of CIHH on expression of TNF-α, IFN-γ, IL-4 and
IL-17 in synovial tissue
The expression of TNF-α, IFN-γ, IL-4 and IL-17 in syn-
ovial tissue of CIHH+CIA rats was decreased markedly
compared with CIA rats (P < 0.05). Compared with con-
trol rats, however, expression of IL-17 in CIHH+CIA
rats was increased (P < 0.05, Figure 4).
The effect of CIHH on serum TNF-α, IFN-γ, IL-4 and IL-17
concentration in rats
The serum TNF-α, IFN-γ, IL-4, the ratio of IFN-γ/IL-4
and IL-17 in CIHH+CIA rats were decreased signifi-
cantly compared with CIA rats (P < 0.05), but were not
changed significantly compared with control rats (P >
0.05, Table 3).
The effect of CIHH on protein expression of HIF-1α and
NF-κB in synovium tissue
The protein expression of HIF-1α in synovium tissue in
CIHH+CIA rats was significantly lower than that in CIA
rats (P<0.05), but was not different compared with Con-
trol rats (P>0.05, Figure 5A).
The protein expression of NF-κB in synovium tissue in
CIHH+CIA rats was significantly lower than that in CIA
rats (P<0.05), but higher than that in Control rats
(P<0.05, Figure 5B).
Discussion
This is the first study to investigate the underlying im-
munological mechanism for the protective effect oftreatment on pathologic morphology of synovial tissue in
l tissue; B: Collageniinduced arthritis (CIA) rats displayed obvious
C: CIHH treated CIA (CIHH+CIA) rats did not displayed significant
Table 2 Effect of chronic intermittent hypobaric hypoxia
(CIHH) pre-treatment CD4 and CD8 in blood of collagen-
induced arthritis rat
Group CD4 (%) CD8 (%) CD4/CD8
CIA (n=6) 30.58±1.59# 22.47±1.63 1.33±0.09#
CIHH+CIA (n=6) 24.62±0.83* 25.08±1.23 0.99±0.03*
Control (n=6) 25.42±1.18 26.02±0.89 0.98±0.04
Data were expressed as mean±SEM; *P < 0.05 vs CIA; #P < 0.05 vs Control.
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CIHH significantly decreased the prevalence of CIA and
effectively alleviated the symptoms of CIA, such as redu-
cing AI value and paw thickness and relieving inflamma-
tory infiltration in synovial tissue. Furthermore, CIHHFigure 4 Effect of chronic intermittent hypobaric hypoxia (CIHH) pret
expression in synovial tissue of collagen-induced arthritis rat. Represe
Control (a), CIA (b), CIHH+CIA (c) and IHS (d). Brown staining indicates prot
groups; CIHH+CIA: CIHH treated CIA group; HIS:Immunohistochemistry sco
for each group, * p<0.05 vs CIA,# p<0.05 vs Control (Immunohistochemistrytreatment inhibited the increasing of IL-4, TNF-α, IL-17
in serum and synovium tissue, kept the balance of CD4/
CD8 T-lymphocytes and IFN-γ/IL-4 in blood, and inhib-
ited the protein expression of HIF-1α and NF-κB in
synovium tissue in CIA rats. These data suggest that
CIHH treatment exerts beneficial effect on CIA in rats,
which was related to inhibition of inflammatory cyto-
kines, regulation of lymphocyte immunity and HIF-1α-
NF-κB signaling pathway.
The ratio of Th1/Th2 lymphocytes reflects balance
state of cellular immune in the body. It was reported
that the inbalance of Th1/Th2 was existed in RA syn-
ovial tissue and blood with inflammatory cytokines IFN-
γ and TNF-а from Th1 cells predominance [12]. Thereatment on TNF-α (A), IL-17 (B), IFN-γ (C) and IL-4 (D) protein
ntative photomicrographs of protein expression in synovial tissue of
ein expression in cytoplasm (arrow). CIA: collagen-induced arthritis
re of protein expression; Data were expressed as mean ± SEM, n = 6
staining × 400).
Table 3 Effect of chronic intermittent hypobaric hypoxia (CIHH) pre-treatment on TNF-α, IL-17, IFN-γ, IL-4 and IFN-γ/
IL-4 in serum of collagen-induced arthritis rat
Group TNF-α (pg/ml) IL-17 (pg/ml) IFN-γ (pg/ml) IL-4 (pg/ml) IFN-γ/IL-4
CIA (n=6) 4.28±0.49# 12.95±0.59# 9.89±0.31# 10.75±0.27 0.92±0.02#
CIHH+CIA (n=6) 2.21±0.36* 10.85±0.65* 7.53±0.27* 9.46±0.41* 0.80±0.05*
Control (n=6) 2.25±0.22 10.54±0.41 7.59±0.56 9.52±0.45 0.81±0.04
Data were expressed as mean±SEM; *P <0.05 vs CIA; #P <0.05 vs Control.
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longs to a subgroup of T-lymphocyte and contributes
importantly to inflammation and autoimmune diseases
[13]. The IL-17, secreted by Th17 cells, is a major ef-
fective factor to induce the production and release of
many inflammatory cytokines such as chemotactic fac-
tors [14]. Previous studies have shown that IL-17 is
involved in RA and has a synergetic effect with TNF-α
on inflammation enhancement [15]. The IL-17 antag-
onist had been proved to have a therapeutic effect on
CIA animals [16]. The result of present study showed
CIHH pretreatment inhibited the increase of IFN-γ,
IL-4 and IL-17, regulated the ratio of IFN-γ/IL-4 (rep-
resents Th1/Th2 lymphocytes) and ratio of CD4/CD8
T-lymphocytes in CIA rats, which indicates that CIHH
protects rat against CIA through keeping the homeo-
stasis of lymphocytes.
It has been known that proinflammatory cytokine-
mediated inflammatory reaction is involved in the patho-
logical changes of RA synovium [17]. TNF-α is one of vital
proinflammatory cytokines in the RA pathogenesis and isFigure 5 Chronic intermittent hypobaric hypoxia pretreatment decrea
collagen-induced arthritis rat. Chronic intermittent hypobaric hypoxia (C
and NF-κB (B) in synovial tissue of collagen-induced arthritis rat. Represent
blots technique (above); Summaries of densitometric scanning of protein n
CIHH + CIA: CIHH pretreatment group; Data were expressed as mean ± SEMproduced by macrophagocyte, CD4-positive T cells, and
natural killer cells. It has been reported that TNF-α exerts
many effects in the RA pathological process. For example,
TNF-α promote the adhesion and permeation of leukocyte
with vascular endothelium, which results in local inflam-
mation [18]. Also, TNF-α enhances the bone destruction,
absorption, and fibroblast hyperplasia, an effect inhibit the
synthesis of bone collagen [19]. Furthermore, TNF-α in-
creases the release of growth factor from synovium, endo-
thelium, and fibroblast to promote pannus formation of
TNF-α [20]. The TNF-α level increases markedly in serum
and joint fluid of RA patient [21,22]. On the other hand,
anti-TNF-α medicine had therapeutic effect on ameliorat-
ing both inflammation and joint damage in rheumatoid
arthritis patient [23]. Also, IL-12 and IFN-γ from Th1 cells
and IL-17 from Th17 cells act as proinflammatory cyto-
kines [24,14]. In the present study, we found that CIHH
treatment reduced the increase of TNF-α, IFN-γ and IL-17
in serum and synovial tissue in CIA rats, suggesting CIHH
may protect rat against CIA through inhibition of inflam-
matory reaction.ses HIF-1α and NF-κB protein expression of synovial tissue in
IHH) pretreatment prevented the protein over expression of HIF-1α (A)
ative photographs of protein expression in synovial tissue by western
ormalized to GADPH (bottom); CIA: collagen-induced arthritis groups;
, n = 6 for each group, * P < 0.05 vs CIA,# P < 0.05 vs Control.
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tor (HIF-1α), two important transcription factors related to
inflammation and hypoxia, have been proved to be involved
in RA [25,26]. Both factors play key role on regulation of in-
flammation gene in RA. NF-κB regulates growth and differ-
entiation of immune cell, participates in regulation of
immune-related and inflammation-related genes, and highly
expresses in pathologic synovium tissue of RA patient [27].
Hypoxic microenvironment in RA contributes to the charac-
terized angiogenesis, pannus and inflammation process, in
which the abnormal activation of HIF-1α pathway was
closely related to inflammation development [28]. While in-
flammation cytokines such as IL-1β and TNF-α can promote
the transcription of HIF-1 [29]. Activated HIF-1α promotes
angiogenesis and inflammation of joint synovium, resulting
in joint cartilage and bone damage [30]. In general, NF-κB
and HIF-1 pathways take action independently. On the other
hand, a “cross-talk” exists between NF-κB and HIF-1 result-
ing in interdependence of them under disease states, such as
ischaemia, pulmonary hypertension, cancer, and a variety of
acute or chronic inflammatory diseases [31,32]. The result of
this study showed that pretreatment of CIHH could abate
the overexpression of NF-κB and HIF-1 in RA rats, which
suggests that CIHH protects rat against RA through modu-
lating signal pathways of NF-κB and HIF-1α.
As stress stimulation, hypoxia is a double-edged sword to
the body. In this regard, severe hypoxia is involves in the
genesis and prognosis of acute and chronic diseases such as
diabetes, cardiovascular diseases, pulmonary edema, and im-
mune disorders [33]. On the other hand, the intensity and
duration controlled hypoxia produces a beneficial effect
through adaptation mechanism [34]. Many studies provide
strong evidence that CIHH has a protective effect on heart,
brain, and liver against ischemia/reperfusion or hypoxia/re-
oxygenation injury [2]. However, limited studies have been
performed regarding the effect of CIHH on immune system
function in immune diseases such as bronchial asthma, al-
lergic dermatoses, and autoimmune thyroiditis [35]. Our
present study demonstrated that CIHH treatment has a pro-
tective effect on experimental CIA in rats, manifesting as de-
crease in incidence of CIA, inhibition of synovial
inflammation, and improvement of the pathological changes
of synovium in CIA rats.
In this study, we investigated the effect of CIHH pre-
treatment on CIA rat and got positive result, which suggests
that CIHH might have a preventive action for RA in clinic.
But we don’t know whether CIHH has treatment effect on
RA. In other words, we do not know whether CIHH post-
treatment has positive effect on CIA rats. It is the limitation
of this study and need further investigation.
In summary, our studies demonstrated for the first
time that CIHH pretreatment has a protective effect on
CIA in rat through reducing the genesis of inflammatory
cytokines TNF-а and IL-17, balancing the homeostasisof T-lymphocyte subsets, and modulating HIF-1α and
NF-κB signal transduction pathways.
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